Motley Fool
Missed Out on Eli Lilly? This GLP-1 Stock Could Be a Bargain Buy.
📈
AI Sentiment
Highly Positive
9/10
Amgen Inc. News
Latest updates and market news for AMGN
17 news
Jan 24 - Jan 30, 2026
Page 1
PR Newswire
AMGEN ANNOUNCES WEBCAST OF 2025 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS
➖
AI Sentiment
Neutral
5/10
Barrons.com
Pharma Stocks Are Close to Breaking Out. Earnings Could Set Them Free.
📈
AI Sentiment
Highly Positive
10/10
GlobeNewswire
Thyroid Eye Disease Market - A Global and Regional Analysis: Focus on Country and Region, 2025-2035
📈
AI Sentiment
Highly Positive
8/10
PR Newswire
TransCelerate BioPharma Showcases Approaches to Advancing Clinical Trial Efficiency and Patient-Centered Design at SCOPE US 2026
📊
AI Sentiment
Positive
7/10
GlobeNewswire
Global Glioma Market Growth Driven by Therapeutic Innovations and Aging Population
📈
AI Sentiment
Highly Positive
8/10
Simply Wall St.
Amgen Lawsuit Over 340B Discounts Puts Pricing And Policy In Focus
➖
AI Sentiment
Neutral
4/10
Zacks
Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for
➖
AI Sentiment
Neutral
4/10
The Wall Street Journal
Roche Obesity Shot Helps Patients Lose Weight in Midstage Trial
📈
AI Sentiment
Highly Positive
8/10
Insider Monkey
Bernstein Calls 2026 a “Waiting Year” for Amgen’s (AMGN) MariTide
📊
AI Sentiment
Positive
6/10
Argus Research
Daily Spotlight: Min Vol: More than a Defensive Strategy
📊
AI Sentiment
Positive
6/10
Simply Wall St.
Amgen's (NASDAQ:AMGN) 11% CAGR outpaced the company's earnings growth over the same five-year period
📊
AI Sentiment
Positive
6/10
StockStory
Q3 Rundown: Amgen (NASDAQ:AMGN) Vs Other Therapeutics Stocks
📈
AI Sentiment
Highly Positive
9/10
Share this news page